These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2573147)
41. Prophylactic and therapeutic role of rioprostil in NSAIDs induced gastroduodenal lesions. Paladini G; Fabiani MG; Tosato F; Maggiolo F Scand J Gastroenterol Suppl; 1989; 164():242-5; discussion 245-6. PubMed ID: 2510276 [TBL] [Abstract][Full Text] [Related]
42. Rioprostil in the short-term treatment of duodenal ulcer: a multicentre double-blind trial vs. cimetidine. Bianchi Porro G; Parente F; Hentschel E; Bennani A; Sebti F; Cherkaoui A; Demyttenaere M; Gouerou H; Blasi A; Darnis F Scand J Gastroenterol Suppl; 1989; 164():219-23. PubMed ID: 2510272 [TBL] [Abstract][Full Text] [Related]
43. Oral E2 prostaglandins affect endocrine cell populations in the gastric antrum of the rat. Uribe A; Grimelius L; Theodorsson LE; Riis-Angelo L; Johansson C Eur J Clin Invest; 1989 Apr; 19(2):146-53. PubMed ID: 2567240 [TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of rioprostil, 300 micrograms b.d., in the treatment of gastric ulcer: a comparison vs. ranitidine, 150 mg b.d., in a randomized multicentre study. Rutgeerts P; Vantrappen G; Businger JA; Demol P; Simon B; Barbier P Scand J Gastroenterol Suppl; 1989; 164():184-90. PubMed ID: 2510265 [TBL] [Abstract][Full Text] [Related]
45. Rioprostil prevents aspirin-induced fecal blood loss in dogs. Correlation of Hemoquant (Hb) with endoscopic findings. Katz LB; Fernandez JA; Schwartz S; Shriver DA Digestion; 1989; 42(4):217-23. PubMed ID: 2509266 [TBL] [Abstract][Full Text] [Related]
46. Treatment of benign gastric ulcer: a comparative clinical trial of rioprostil and ranitidine. Quinton A; Goldfain D; Weber F; Briaud M; Plane D; Bancons J; Monneris R; Audigier JC; Arnal JC; Lacoste D Scand J Gastroenterol Suppl; 1989; 164():178-82; discussion 182-3. PubMed ID: 2510264 [TBL] [Abstract][Full Text] [Related]
47. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing. Simon B; Dammann HG; Müller P Klin Wochenschr; 1986; 64 Suppl 7():44-6. PubMed ID: 3104657 [TBL] [Abstract][Full Text] [Related]
48. Altered susceptibility of arthritic rats to the gastric lesion-inducing effects of aspirin or ethanol and the antilesion effect of rioprostil. Katz LB; Genna T; Fuller BL; Tolman EL; Shriver DA Agents Actions; 1987 Oct; 22(1-2):134-43. PubMed ID: 3120518 [TBL] [Abstract][Full Text] [Related]
49. Rioprostil, a new prostaglandin E1 analogue, in the once-daily treatment of acute duodenal ulcer: a comparison with ranitidine. Businger JA; Miglio F; Gasbarrini T; Vismans FJ; Geraedts AA; Stocker H Scand J Gastroenterol Suppl; 1989; 164():161-7; discussion 167-8. PubMed ID: 2510261 [TBL] [Abstract][Full Text] [Related]
50. Rioprostil prevents gastric bleeding induced by nonsteroidal antiinflammatory drugs in dogs and arthritic rats. Katz LB; Capetola RJ; Argentieri DC; Moore LE; Genna T; Porter MC; Jasty V; Hartnagel RE; Abrutyn D; Shriver DA J Rheumatol; 1986 Oct; 13(5):887-94. PubMed ID: 3102726 [TBL] [Abstract][Full Text] [Related]
51. Rioprostil, a new prostaglandin E1 analogue, in the once-daily treatment for the prevention of duodenal ulcer recurrence: a comparison with ranitidine. Businger JA; Fumagalli I; Michel H; Delas N; Stocker H Scand J Gastroenterol Suppl; 1989; 164():152-9; discussion 159-60. PubMed ID: 2510260 [TBL] [Abstract][Full Text] [Related]
52. The synthetic prostaglandin E1 analogue rioprostil reduces the nephrotoxic potential of cyclosporine A. Metz-Kurschel U; Wagner K; Mueller MK Transplant Proc; 1990 Aug; 22(4):1713-6. PubMed ID: 1975139 [TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics of rioprostil in rats. Petersen-von Gehr JK; Siefert HM; Steinke W Scand J Gastroenterol Suppl; 1989; 164():46-50; discussion 50-1. PubMed ID: 2510280 [TBL] [Abstract][Full Text] [Related]
54. Antiulcer effect of rioprostil, a prostaglandin E1 analog, in combination with antacid. Katz LB; Genna T; Shriver DA Life Sci; 1986 Sep; 39(11):1013-9. PubMed ID: 3091974 [TBL] [Abstract][Full Text] [Related]
55. The interaction of the prostaglandin E derivative rioprostil with oral anticoagulant agents. Thijssen HH; Hamulyàk K Clin Pharmacol Ther; 1989 Jul; 46(1):110-6. PubMed ID: 2501056 [TBL] [Abstract][Full Text] [Related]
56. Effect of prostaglandin on indomethacin-induced increased intestinal permeability in man. Bjarnason I; Smethurst P; Clark P; Menzies I; Levi J; Peters T Scand J Gastroenterol Suppl; 1989; 164():97-102; discussion 102-3. PubMed ID: 2510288 [TBL] [Abstract][Full Text] [Related]
57. Treatment of duodenal ulcer with rioprostil: a randomized multicentre double-blind study. Boucekkine T; Meknini B; Bitoun A; Prunièras F; Khedis A; de Lauture D; Rotenberg A; Molinie C; Roux M; Gauthier A Scand J Gastroenterol Suppl; 1989; 164():191-3. PubMed ID: 2510266 [TBL] [Abstract][Full Text] [Related]
58. G- and D-cell populations, serum and tissue concentrations of gastrin and somatostatin in patients with peptic ulcer diseases. Park SM; Park HS Korean J Intern Med; 1993 Jan; 8(1):1-7. PubMed ID: 7903552 [TBL] [Abstract][Full Text] [Related]
59. Slow release delivery of rioprostil by an osmotic pump inhibits the formation of acute aspirin-induced gastric lesions in dogs and accelerates the healing of chronic lesions without incidence of side effects. Katz LB; Shriver DA Toxicol Appl Pharmacol; 1989 Oct; 101(1):36-46. PubMed ID: 2508266 [TBL] [Abstract][Full Text] [Related]
60. The effects of rioprostil on gastric emptying and intragastric acidity. Penston JG; Johnston DA; Wormsley KG Hepatogastroenterology; 1986 Jun; 33(3):120-2. PubMed ID: 3091468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]